• Congratulations to Dr. Doug Lowy and Dr. John Schiller

    Read more...

  • Steven D. Cappell, Ph.D.

    Steven Cappell appointed as new Stadtman Investigator

    Learn more...

  • Researchers hope targeted radionuclide therapy, which involves a drug consisting of a radioactive atom tethered to a molecule that targets tumor cells, could slow progression of PHEO/PGL.

    Clinical trial will investigate targeted radionuclide therapy for inoperable rare tumors

    Learn more...

  • Clinical trial aims to study immunotherapy for central nervous system tumors

    Read more...

  • Immunotherapy cells

    CAR T-Cell therapy can lead to long-lasting remissions in patients with lymphoma

    Read more...